Product Information
CLARITHROMYCIN ER 500 MG TAB is a generic product labeled by Chartwell RX LLC, priced at $1.9182 per EA under NDC 62135088360. Its NADAC has been published 71 times since May 28, 2025.
FDA first approved this application on Jul 9, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Chartwell RX LLCNDC
62135088360
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLARITHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA208987FDA Approved
7/9/2018
TE Code
AB
On Market Since
9/10/2019
Pharmacological Classes
Price Statistics
The NADAC for CLARITHROMYCIN ER 500 MG TAB has been published 71 times since May 28, 2025, and over the history we have for it it has declined 43.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9182 per EA |
|---|---|
| All-time high | $3.6800 (Sep 10, 2025) |
| All-time low | $1.8978 (Aug 19, 2026) |
| 52-week high | $3.6782 |
| 52-week low | $1.8978 |
| Median price | $3.0700 |
| Average price | $3.0244 |
| Largest weekly change | -15.1% (Aug 19, 2026) |
| Weeks tracked | 71 |
| Tracking since | May 28, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CLARITHROMYCIN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CLARITHROMYCIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Macrolide Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLARITHROMYCIN ER 500 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for CLARITHROMYCIN ER 500 MG TAB, manufactured by Chartwell RX LLC, is $1.9182 per EA (NDC 62135088360), effective Sep 30, 2026.
How has the price of CLARITHROMYCIN ER 500 MG TAB changed over time?
Over the history we have for it, the NADAC for CLARITHROMYCIN ER 500 MG TAB has declined 43.0%. It has been tracked across 71 weekly CMS publications since May 28, 2025.
What are the highest and lowest recorded NADAC prices for CLARITHROMYCIN ER 500 MG TAB?
Since May 28, 2025, the NADAC for CLARITHROMYCIN ER 500 MG TAB has ranged from a low of $1.8978 (Aug 19, 2026) to a high of $3.6800 (Sep 10, 2025), with a median of $3.0700 per EA.
Are there cheaper alternatives to CLARITHROMYCIN ER 500 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of CLARITHROMYCIN ER 500 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CLARITHROMYCIN ER 500 MG TAB?
CLARITHROMYCIN ER 500 MG TAB (NDC 62135088360) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.